AD

Anumandla Divya Sri

Active Director Director DIN 09117291
DIN 09117291 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Anumandla Divya Sri

Data last updated:

Anumandla Divya Sri is a Director at Systomed Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Systomed Pharmaceuticals Private Limited reported revenue of ₹17.1 Lakh (FY 2023).

DIN 09117291
Primary Designation Director
Industry Trading
First Appointment 22 Mar 2021
Oldest Company Age 5 yrs
Largest company Systomed Pharmaceuticals Private Limited · ₹17.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20212021₹17.1 Lakh (FY 2023)Active

Board colleagues of Anumandla Divya Sri

NameDINCompanyDesignation
Srikanth Chiluka09117292Systomed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Systomed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anumandla Divya Sri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anumandla Divya Sri

Anumandla Divya Sri currently holds 1 directorship: Systomed Pharmaceuticals Private Limited (Director, since 22 Mar 2021, revenue ₹17.1 Lakh (FY 2023)).

Anumandla Divya Sri was first appointed on 22 Mar 2021 as Director at Systomed Pharmaceuticals Private Limited.

The current boards of Anumandla Divya Sri's companies include Srikanth Chiluka (Systomed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available